Log In
Print
BCIQ
Print
Print this Print this
 

STX-100

  Manage Alerts
Collapse Summary General Information
Company Biogen Idec Inc.
DescriptionHumanized mAb against integrin alpha(V)beta(6)
Molecular Target Integrin alpha(V)beta(6)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase II
Standard IndicationPulmonary fibrosis
Indication DetailsTreat idiopathic pulmonary fibrosis (IPF)
Regulatory Designation

U.S. - Orphan Drug (Treat idiopathic pulmonary fibrosis (IPF))

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today